
Ocular Therapeutix, Inc.: shareholders and insiders
Price
$5.94
November 18, 2026Market cap $1.3B
What Ploutos Investor adds for Ocular Therapeutix
Part of Ploutos Investor, €9.99 a month
- The full history: 13 fiscal years, from 2012
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
Insiders and their shares
Purchases and sales by officers and directors, from their own Form 4 filings.
Reading the newest filings from the SEC. This part fills in on its own in a few seconds.
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- FMRwith 1 more personShare of class15.0%
- Deep Track Capital, LPwith 2 more personsShare of class9.53%
- BlackRock, Inc.Share of class7.00%
- Summer RoadShare of class5.70%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| FMRwith 1 more person | 15.0% | 31.79M | Nov 5, 20252 filings since Jul 8, 2025 | 13G/A | |
| Deep Track Capital, LPwith 2 more persons | 9.53% | 20.85M | May 15, 20265 filings since May 15, 2025 | 13G/A | |
| BlackRock, Inc. | 7.00% | 15.23M | Jul 29, 20262 filings since Oct 17, 2025 | 13G/A | |
| Summer Road | 5.70% | 12.13M | Dec 8, 2025 | 13G |
Fell to 5% or less (3)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Renaissance TechnologiesIn the quarter+43%
- Point72 (Cohen)In the quarter-91%
- Citadel Advisors (Griffin)In the quarter+42%
- D.E. ShawIn the quarter+2.6%
- AQR CapitalIn the quarter+17%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Renaissance Technologies | 540.9K | +43% | $4.1M | 0.01% |
| Point72 (Cohen) | 283.6K | -91% | $2.2M | 0.00% |
| Citadel Advisors (Griffin) | 441.8K | +42% | $3.4M | 0.00% |
| D.E. Shaw | 127.7K | +2.6% | $1.0M | 0.00% |
| AQR Capital | 1.12M | +17% | $8.6M | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 13.2% of its shares outstanding were held short, -2.2% since the report before.
- Shares held short
- 28.76M
- 13.2%
- Since the report before29.41M on Sep 30, 2026
- -2.2%
- 8.1
- 3.55M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 84%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 4.76M
- Nov 15, 2023: Shares held short 5.81M
- Nov 30, 2023: Shares held short 5.28M
- Dec 15, 2023: Shares held short 4.54M
- Dec 29, 2023: Shares held short 4.38M
- Jan 12, 2024: Shares held short 3.35M
- Jan 31, 2024: Shares held short 3.96M
- Feb 15, 2024: Shares held short 3.97M
- Feb 29, 2024: Shares held short 4.74M
- Mar 15, 2024: Shares held short 9.16M
- Mar 28, 2024: Shares held short 11.81M
- Apr 15, 2024: Shares held short 14.65M
- Apr 30, 2024: Shares held short 21.08M
- May 15, 2024: Shares held short 21.22M
- May 31, 2024: Shares held short 22.47M
- Jun 14, 2024: Shares held short 23.37M
- Jun 28, 2024: Shares held short 21.34M
- Jul 15, 2024: Shares held short 20.38M
- Jul 31, 2024: Shares held short 19.09M
- Aug 15, 2024: Shares held short 18.77M
- Aug 30, 2024: Shares held short 18.35M
- Sep 13, 2024: Shares held short 17.46M
- Sep 30, 2024: Shares held short 16.19M
- Oct 15, 2024: Shares held short 13.26M
- Oct 31, 2024: Shares held short 12.67M
- Nov 15, 2024: Shares held short 10.78M
- Nov 29, 2024: Shares held short 10.66M
- Dec 13, 2024: Shares held short 10.47M
- Dec 31, 2024: Shares held short 10.74M
- Jan 15, 2025: Shares held short 11.16M
- Jan 31, 2025: Shares held short 10.87M
- Feb 14, 2025: Shares held short 11.60M
- Feb 28, 2025: Shares held short 12.05M
- Mar 14, 2025: Shares held short 12.83M
- Mar 31, 2025: Shares held short 12.59M
- Apr 15, 2025: Shares held short 14.10M
- Apr 30, 2025: Shares held short 12.98M
- May 15, 2025: Shares held short 13.83M
- May 30, 2025: Shares held short 14.26M
- Jun 13, 2025: Shares held short 14.42M
- Jun 30, 2025: Shares held short 14.17M
- Jul 15, 2025: Shares held short 14.80M
- Jul 31, 2025: Shares held short 12.83M
- Aug 15, 2025: Shares held short 13.08M
- Aug 29, 2025: Shares held short 13.84M
- Sep 15, 2025: Shares held short 15.28M
- Sep 30, 2025: Shares held short 13.56M
- Oct 15, 2025: Shares held short 13.59M
- Oct 31, 2025: Shares held short 13.77M
- Nov 14, 2025: Shares held short 13.17M
- Nov 28, 2025: Shares held short 11.63M
- Dec 15, 2025: Shares held short 10.59M
- Dec 31, 2025: Shares held short 12.35M
- Jan 15, 2026: Shares held short 12.79M
- Jan 30, 2026: Shares held short 11.51M
- Feb 13, 2026: Shares held short 14.71M
- Feb 27, 2026: Shares held short 17.65M
- Mar 13, 2026: Shares held short 23.68M
- Mar 31, 2026: Shares held short 25.19M
- Apr 15, 2026: Shares held short 24.53M
- Apr 30, 2026: Shares held short 24.79M
- May 15, 2026: Shares held short 24.78M
- May 29, 2026: Shares held short 25.09M
- Jun 15, 2026: Shares held short 26.46M
- Jun 30, 2026: Shares held short 26.70M
- Jul 15, 2026: Shares held short 27.03M
- Jul 31, 2026: Shares held short 26.74M
- Aug 14, 2026: Shares held short 28.52M
- Aug 31, 2026: Shares held short 28.06M
- Sep 15, 2026: Shares held short 29.93M
- Sep 30, 2026: Shares held short 29.41M
- Oct 15, 2026: Shares held short 28.76M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading48.0% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 48.0% of the shares in the reported trades were short sales, against 55.8% in the 14 before.
- Last 14 sessionsOct 29, 2026 – Nov 17, 2026
- 48.0%
- The 14 beforeOct 9, 2026 – Oct 28, 2026
- 55.8%
- Change
- -7.8 pts
- Short sales a dayon average, of 1.31M shares
- 628.4K
- More than atof 3,659 US-listed companies, same days
- 42%
- Median of alleight in ten from 34.6% to 63.7%
- 50.3%
- Short sales
- Oct 9, 2026: Short sales 54.2%
- Oct 12, 2026: Short sales 58.3%
- Oct 13, 2026: Short sales 57.1%
- Oct 14, 2026: Short sales 61.1%
- Oct 15, 2026: Short sales 38.1%
- Oct 16, 2026: Short sales 75.4%
- Oct 19, 2026: Short sales 59.9%
- Oct 20, 2026: Short sales 41.3%
- Oct 21, 2026: Short sales 62.4%
- Oct 22, 2026: Short sales 52.6%
- Oct 23, 2026: Short sales 60.7%
- Oct 26, 2026: Short sales 56%
- Oct 27, 2026: Short sales 47.5%
- Oct 28, 2026: Short sales 54%
- Oct 29, 2026: Short sales 53.1%
- Oct 30, 2026: Short sales 30.8%
- Nov 2, 2026: Short sales 45.4%
- Nov 3, 2026: Short sales 45.7%
- Nov 4, 2026: Short sales 43.9%
- Nov 5, 2026: Short sales 62.5%
- Nov 6, 2026: Short sales 64.3%
- Nov 9, 2026: Short sales 60.7%
- Nov 10, 2026: Short sales 40.1%
- Nov 11, 2026: Short sales 45%
- Nov 12, 2026: Short sales 64.2%
- Nov 13, 2026: Short sales 55%
- Nov 16, 2026: Short sales 49.9%
- Nov 17, 2026: Short sales 37.6%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IHEiShares U.S. Pharmaceuticals ETFWeight in the fund0.39%
- IWOiShares Russell 2000 Growth ETFWeight in the fund0.10%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.07%
- IWMiShares Russell 2000 ETFWeight in the fund0.06%
- SCHASchwab U.S. Small-Cap ETFWeight in the fund0.04%
- DFASDimensional U.S. Small Cap ETFWeight in the fund0.04%
- IWNiShares Russell 2000 Value ETFWeight in the fund0.02%
- VHTVanguard Health Care Index FundWeight in the fund0.02%
- VXFVanguard Extended Market Index FundWeight in the fund0.02%
- ONEQFidelity Nasdaq Composite Index ETFWeight in the fund0.01%
16 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 216
- Q4 2025: Managers 249
- Q1 2026: Managers 274
- Q2 2026: Managers 262
Institutional investors by quarter
The fund managers holding OCUL, quarter by quarter, from Q3 2014 to Q2 2025, 44 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 262 managers held 207M shares, worth $2.0B. During the quarter 34 opened a position, 46 closed one, 105 added and 78 trimmed.
The largest holders, Q2 2026
- FMRIn the quarter+0.6%
- Deep Track CapitalIn the quarter
- BlackRockIn the quarter+20%
- Avoro Capital AdvisorsIn the quarter+1.8%
- Summer RoadIn the quarter+2.8%
- Venrock AdviserIn the quarter
- Vanguard Capital ManagementIn the quarter+1.3%
- Price T Rowe AssociatesIn the quarter+29%
- Logos Global ManagementIn the quarter+38%
- State StreetIn the quarter+11%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| FMR | 32.84M | +0.6% | $323M |
| Deep Track Capital | 19.69M | $193M | |
| BlackRock | 19.38M | +20% | $190M |
| Avoro Capital Advisors | 12.54M | +1.8% | $123M |
| Summer Road | 12.21M | +2.8% | $120M |
| Venrock Adviser | 10.35M | $102M | |
| Vanguard Capital Management | 8.83M | +1.3% | $87M |
| Price T Rowe Associates | 7.62M | +29% | $75M |
| Logos Global Management | 5.30M | +38% | $52M |
| State Street | 5.23M | +11% | $51M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Ocular Therapeutix's filings show?
Who buys and sells is one part of Ocular Therapeutix's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Which well-known managers hold OCUL?
5 of the managers we track held the shares on Sep 30, 2026. The largest position was AQR Capital's, worth $8.6M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.